Dragon Life Science Holdings Group, Inc.
NOHO · OTC
5/31/2023 | 2/28/2023 | 2/28/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6.1% | – | – | – |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | 1.4% | -65.4% | – | – |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -12,899.6% | 6,670.4% | – | – |
| Net Income | -$0 | -$0 | $0 | -$0 |
| % Margin | -14,881.5% | -2,962.1% | – | – |
| EPS Diluted | -0 | -0 | 0 | -0 |
| % Growth | -432.9% | -102.6% | 3,317.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |